|
|
| Clinical Network Services |
| |
|
Headquartered in Brisbane, CNS is an Australian based contract research organisation (CRO) providing clinical management support to the healthcare community during the early phase clinical development of their products. CNS is Queensland’s leading educator of clinical research professionals and provider of quality consultation to all parts of the industry. CNS combines a responsive, internationally experienced team, with preferred partners and networks, resulting in the provision of innovative clinical research, quality and educational solutions. CNS is perfectly suited to clients in need of a quality-focused Contract Research Organisation.
Using Australian clinical sites, CNS provides international Pharmaceutical, Nutraceutical, and Medical Device companies with an opportunity to establish safety and proof of concept of their products in a regulatory environment that is both timely and cost effective. CNS has a growing list of satisfied and repeat clients from the USA, Europe and Asia for whom it has managed their early phase clinical trials across Australia and New Zealand. CNS is happy to work directly with “sponsor” companies or other CROs.
CNS as a clinical trial planner:
Protocol design, Study sponsorship for non Australian companies, Regulatory consultancy, Recruitment, Specialist product development advice, Imports/packaging
CNS as a clinical trial manager:
Study management, Site monitoring, Data management, Biostatistics, PK/PD modelling
CNS as a quality consultant:
Site/Unit capability assessments. Site/institution quality system consultancy, Clinical GCP review of sites
CNS as a trainer:
ACRP accredited courses – GCP for Clinical Research Professionals – GCP Practical Applications – GCP for Principal Investigators. Tailored training.
Our customers say
"We really appreciate how quickly you were able to execute the agreements to start our trial. Your team has been outstanding and very responsive. Nothing but compliments from CTI."
Timothy J. Schroeder
President & CEO
CTI Clinical Trial & Consulting Services
"We chose Australia as the location for our first in human study based on considerations of quality, subject availability, shared culture and cost. However, as a small California company with less than 40 employees, we were concerned about the feasibility of an international clinical trial. CNS and their Phase 1 partners were highly responsive to our needs. An effective relationship soon developed which led to high quality and rapid implementation of the project in Australia."
Patricia A Walicke
Vice President Clinical and Regulatory Affairs
Avidia, Inc.
“During my career I have worked with many clinical sites and CROs, but I can unequivocally state that I have never had a more positive experience than I have had with your organization.”
Mark Roffman, PhD
VP Clinical and Regulatory Affairs
Agile Therapeutics Inc.
"I didn’t find the distance from the United States to be a problem. One of the advantages to Agile Therapeutics was that the per patient cost was slightly lower than the cost in the United States and was significantly lower when the currency difference was taken into consideration."
Thomas Stagnaro
President
Agile Therapeutics, Inc
www.clinical.net.au
| |
|
|
|
|
|
|
|
|
|
|